Dermatitis Eczema Pharmaceutical 
The Dermatology Digest
FEBRUARY 8, 2024
Dupilumab (Dupixent, Regeneron Pharmaceuticals, Inc., Peter Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago, agrees that it is going to be a big year for eczema patients and the doctors who treat them. “I
The Dermatology Digest
OCTOBER 26, 2024
Atopic dermatitis (AD) patients who switched to upadacitinib (Rinvoq, AbbVie) from dupilumab (Dupixent, Regeneron, and Sanofi) hit higher treatment targets, according to results from Period 2 of the LEVEL UP study. achieved an Eczema Area and Severity Index (EASI) of 75, 90, and 100, respectively. In the switchers, 47.6%
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Dermatology Digest
JANUARY 16, 2024
Food and Drug Administration (FDA) has updated the label for dupilumab (Dupixent, Regeneron Pharmaceuticals, Inc. and Sanofi), adding efficacy and safety data for people aged 12 years and older with atopic dermatitis (AD) and uncontrolled moderate-to-severe hand and/or foot involvement. and Sanofi report. “We
The Dermatology Digest
MARCH 11, 2024
Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Watch Now Chronic Hand Eczema 101 Jonathan Silverberg, MD, PhD, MPH Chronic hand eczema (CHE) symptoms can take a dramatic toll on patients’ quality of life. Watch Now The Lowdown on Molluscum Nanette B.
The Dermatology Digest
APRIL 22, 2024
Adult atopic dermatitis (AD) patients previously treated with dupilumab (Dupixent, Regeneron and Sanofi) who received 400mg eblasakimab weekly achieved Eczema Area Severity Index (EASI) 90, and 66.7% achieved a Validated Investigator Global Assessment (vIGA) score of 0 or 1 after 16 weeks compared to 14.3%
The Dermatology Digest
MARCH 10, 2024
Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Watch Now Chronic Hand Eczema 101 Jonathan Silverberg, MD, PhD, MPH Chronic hand eczema (CHE) symptoms can take a dramatic toll on patients’ quality of life. Watch Now The Lowdown on Molluscum Nanette B.
The Dermatology Digest
MARCH 11, 2024
Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions. Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Watch Now The Lowdown on Molluscum Nanette B.
Expert insights. Personalized for you.
78 
Let's personalize your content